1. EphrinB2-EphB4-RASA1 Signaling in Human Cerebrovascular Development and Disease
- Author
-
Sheng Chih Jin, Jonathan Gaillard, Daniel Duran, Xue Zeng, Kristopher T. Kahle, and Ava Hunt
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Receptor, EphB4 ,Neovascularization, Physiologic ,Ephrin-B2 ,Disease ,Bioinformatics ,Article ,Structure-Activity Relationship ,03 medical and health sciences ,0302 clinical medicine ,Vasculogenesis ,medicine ,Animals ,Humans ,Genetic Predisposition to Disease ,Molecular Biology ,Exome sequencing ,business.industry ,p120 GTPase Activating Protein ,Arteriovenous malformation ,medicine.disease ,Phenotype ,Pathophysiology ,Cerebrovascular Disorders ,030104 developmental biology ,Somatic mosaicism ,Molecular Medicine ,Disease Susceptibility ,Neurosurgery ,business ,030217 neurology & neurosurgery ,Signal Transduction - Abstract
Recent whole exome sequencing studies in humans have provided novel insight into the importance of the ephrinB2-EphB4-RASA1 signaling axis in cerebrovascular development, corroborating and extending previous work in model systems. Here, we aim to review the human cerebrovascular phenotypes associated with ephrinB2-EphB4-RASA1 mutations, including those recently discovered in Vein of Galen malformation – the most common and severe brain arteriovenous malformation in neonates. We will also discuss emerging paradigms of the molecular and cellular pathophysiology of disease-causing ephrinB2-EphB4-RASA1 mutations, including the potential role of somatic mosaicism. These observations have potential diagnostic and therapeutic implications for patients with rare congenital cerebrovascular diseases and their families.
- Published
- 2019
- Full Text
- View/download PDF